283 related articles for article (PubMed ID: 27756894)
1. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
Ao R; Wang Y; Tong J; Wang BF
Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
[TBL] [Abstract][Full Text] [Related]
2. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
[TBL] [Abstract][Full Text] [Related]
3. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
4. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of microRNA-29a regulating steatosis in the human hepatocyte via targeting silent mating type information regulation 2 homolog-1].
Qin W; Wang J; Wang L; Zhuo Q; Yang Z
Wei Sheng Yan Jiu; 2021 Mar; 50(2):284-288. PubMed ID: 33985638
[TBL] [Abstract][Full Text] [Related]
6. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells.
Borji M; Nourbakhsh M; Shafiee SM; Owji AA; Abdolvahabi Z; Hesari Z; Ilbeigi D; Seiri P; Yousefi Z
Biochem Genet; 2019 Aug; 57(4):507-521. PubMed ID: 30697640
[TBL] [Abstract][Full Text] [Related]
7. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR.
Sun C; Huang F; Liu X; Xiao X; Yang M; Hu G; Liu H; Liao L
Int J Mol Med; 2015 Mar; 35(3):847-53. PubMed ID: 25605429
[TBL] [Abstract][Full Text] [Related]
8. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
9. microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes.
Yousefi Z; Nourbakhsh M; Abdolvahabi Z; Ghorbanhosseini SS; Hesari Z; Yarahmadi S; Ezzati-Mobasser S; Seiri P; Borji M; Meshkani R; Malek M
J Cell Physiol; 2020 Feb; 235(2):880-890. PubMed ID: 31256424
[TBL] [Abstract][Full Text] [Related]
10. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
[TBL] [Abstract][Full Text] [Related]
11. miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis.
Yang YL; Wang PW; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961796
[TBL] [Abstract][Full Text] [Related]
12. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
14. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
15. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
17. miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease.
Ali O; Darwish HA; Eldeib KM; Abdel Azim SA
Oxid Med Cell Longev; 2018; 2018():8515343. PubMed ID: 30402207
[TBL] [Abstract][Full Text] [Related]
18. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish.
Lai CY; Lin CY; Hsu CC; Yeh KY; Her GM
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):844-856. PubMed ID: 29678641
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
20. GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway.
Wang Y; Zeng Z; Guan L; Ao R
J Cell Mol Med; 2020 Jun; 24(11):6107-6119. PubMed ID: 32324317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
